Swiss drug manufacturer Novartis announced that the European Commission has approved Zykadia (ceritinib), a drug used to treat patients suffering from an advanced form of non-small cell lung cancer.
Swiss drug manufacturer Novartis announced that the European Commission has approved Zykadia (ceritinib), a drug used to treat patients suffering from an advanced form of non-small cell lung cancer.
Share this Article
Recommended